{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["21(1)"],"submitter":["Liu H"],"pubmed_abstract":["<h4>Objective</h4>This study aimed to develop a simplified diagnostic tool for assessing sarcopenia and myosteatosis in gastrointestinal cancer patients, focusing on the creatinine to cystatin C ratio (CCR) as an evaluation marker.<h4>Methods</h4>955 patients were split into training (n = 671) and validation (n = 284) cohorts. Using logistic regression, risk factors for sarcopenia and myosteatosis were identified. The predictive capacity of the developed model was examined. The association between CCR and muscle imaging parameters, along with its impact on clinical outcomes, was analyzed.<h4>Results</h4>No significant differences were observed in baseline traits between cohorts. CCR emerged as a significant risk factor for both sarcopenia and myosteatosis. Nomograms for diagnosing these co"],"journal":["Journal of translational medicine"],"pagination":["744"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10589997"],"repository":["biostudies-literature"],"pubmed_title":["Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker."],"pmcid":["PMC10589997"],"pubmed_authors":["Liu H","Yan M","Zhang Z","Sui X","Tan S","Han J","Wu G","Wang J","Yang F"],"additional_accession":[]},"is_claimable":false,"name":"Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker.","description":"<h4>Objective</h4>This study aimed to develop a simplified diagnostic tool for assessing sarcopenia and myosteatosis in gastrointestinal cancer patients, focusing on the creatinine to cystatin C ratio (CCR) as an evaluation marker.<h4>Methods</h4>955 patients were split into training (n = 671) and validation (n = 284) cohorts. Using logistic regression, risk factors for sarcopenia and myosteatosis were identified. The predictive capacity of the developed model was examined. The association between CCR and muscle imaging parameters, along with its impact on clinical outcomes, was analyzed.<h4>Results</h4>No significant differences were observed in baseline traits between cohorts. CCR emerged as a significant risk factor for both sarcopenia and myosteatosis. Nomograms for diagnosing these co","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Oct","modification":"2025-04-04T11:00:22.794Z","creation":"2025-04-04T11:00:22.794Z"},"accession":"S-EPMC10589997","cross_references":{"pubmed":["37864250"],"doi":["10.1186/s12967-023-04628-z"]}}